Coca-Cola Stock Surges to Record Highs on Blowout Earnings

Analysts were divided coming into today

by Emma Duncan

Published on Jan 30, 2020 at 11:09 AM

Beverage powerhouse and Dow stock Coca-Cola Co (NYSE:KO) is enjoying a nice 2.9% post-earnings lift this morning, last seen trading near a fresh record high of $58.63. The company reported a better-than-expected fourth-quarter earnings and revenue beat, as well as topline growth after an increase in demand for its signature brand and Fuze tea lines.

Even ahead of today's earnings blowout, Coca-Cola stock was an outperformer on the charts. Now up 21% year-over-year, KO has been a beneficiary of the 80-day moving average since earlier this month, as well as back in May of last year. 

Analysts have yet to weigh in on the security. However, heading into today covering firms were almost evenly split, with seven sporting a "hold" and six a "strong buy" recommendation. 

Options traders are far from quiet, however, with 25,000 calls and 8,900 puts crossing the tape so far -- four times the expected rate. Most popular looks to be the weekly 2/7 58-strike put and March 60 call, with positions being opened at the former. 

Digging deeper, the stock's Schaeffer's open interest ratio (SOIR) of 0.55 ranks in just the 10th percentile of its annual range. This suggests short-term options players have rarely been more call-heavy during the last 12 months. 

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Cannabis Stock Rally Cut Short after Downgrade
Aurora Cannabis did receive a price-target hike from Jefferies, though
Vaccines, China Trigger Roller Coaster Week for Stocks
Moderna's vaccine captured the attention of Wall Street
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.